Meprate 30mg Tablet SR
Marketer
Serum Institute Of India Ltd
Salt Composition
Medroxyprogesterone acetate (30mg)
Overview Meprate 30mg Tablet SR
Progestin-based Meprate 30mg SR tablets mimic the body's natural progesterone. This medication regulates menstrual cycles, controls abnormal uterine bleeding, and induces withdrawal bleeding in amenorrhea. Dosage and duration are determined solely by your physician. Administration with or without food is acceptable, though consistent timing is recommended. Continue use as directed by your doctor. Common side effects, including headache, abdominal discomfort, fatigue, vertigo, and weight increase, should be reported to your physician; management strategies may be available. Irregular bleeding or spotting between periods may also occur and warrants medical consultation if persistent. Prior to initiating treatment, inform your physician of any prior bleeding disorders, history of thrombosis, cardiovascular events, hepatic dysfunction, or bleeding tendencies. Full disclosure of all other medications is crucial, as drug interactions may impair Meprate's efficacy or alter its effects. This medication is contraindicated during pregnancy and lactation.
Uses of Meprate 30mg Tablet SR
Managing dysfunctional uterine bleeding, addressing amenorrhea, and treating endometriosis.
Major Benefits of Meprate 30mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 30mg Meprate SR tablet whole; avoid chewing, crushing, or breaking it. While food is not required, consistent daily timing is recommended for optimal results.
Common Side effects of Meprate 30mg Tablet SR:
- Headache
- Abdominal pain
- Weakness
- Dizziness
- Irregular menstrual cycle
- Nervousness
- Weight gain
How to use Meprate 30mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meprate 30mg Sustained-Release Tablets can be consumed with or without food, though consistent timing is recommended.
How Meprate 30mg Tablet SR works:
Meprate 30mg Extended-Release Tablets contain a progestin, a type of female hormone. Its mechanism of action involves supplementing progesterone, a hormone the body may not adequately produce. This addresses menstrual irregularities characterized by pain, infrequency, or absence. Furthermore, it mitigates uterine lining hyperplasia in postmenopausal women receiving estrogen therapy.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Meprate 30mg Tablet SR and alcohol. Seek medical advice before doing so.
PregnancyUNSAFE
The extended-release 30mg Meprate tablet presents a substantial risk during pregnancy. Pregnant women should consult their physician immediately, as research in both animal and human subjects indicates considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Sustained-release meprate tablets (30mg) are likely unsuitable for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 30mg slow-release Meprate tablet might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, the extended-release Meprate 30mg tablet requires careful administration. Dosage modification of Meprate 30mg Tablet SR may be necessary; physician consultation is recommended.
LiverUNSAFE
Extended-release Meprate 30mg tablets may pose a risk to individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Meprate 30mg Tablet SR :
Should you forget a dose of your Meprate 30mg SR tablet, take it immediately if you remember. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Meprate 30mg Tablet SR
| Label | Value |
|---|---|
| Chemical Classification | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
3,018 People bought this recently